These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 45285)

  • 1. Effect of beta-blocking agents in hyperthyroidism.
    Földes J; Bános C; Borvendég J; Gyertyánfy G
    Acta Med Acad Sci Hung; 1979; 36(4):375-80. PubMed ID: 45285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of beta-blocking agents on the increased serum gastrin levels in hyperthyroidism.
    Földes J; Bános C; Borvendég J
    Acta Med Acad Sci Hung; 1980; 37(4):351-6. PubMed ID: 6112837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of propranolol, atenolol and metoprolol on the serum levels of thyroxin (T4) and triiodothyronine (T3).
    Shikara MM; Maniar R; Steier W; Rao S; Gintautas J
    Proc West Pharmacol Soc; 2003; 46():127. PubMed ID: 14699907
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of beta receptor blockaders on hyperthyroidism].
    Földes J; Bános C; Borvendég J; Gyertyánfy G
    Orv Hetil; 1979 May; 120(18):1080-2. PubMed ID: 35773
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of propranolol and atenolol on plasma and urinary cyclic adenosine 3',5'-monophosphate in hyperthyroid patients.
    Nilsson OR; Andersson RG; Karlberg BE
    Acta Endocrinol (Copenh); 1980 May; 94(1):38-45. PubMed ID: 6247872
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative effectiveness of carvedilol and propranolol on glycemic control and insulin resistance associated with L-thyroxin-induced hyperthyroidism--an experimental study.
    Bhatt P; Makwana D; Santani D; Goyal R
    Can J Physiol Pharmacol; 2007 May; 85(5):514-20. PubMed ID: 17632586
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative influence of propranolol and verapamil on glycemic control and histamine sensitivity associated with L-thyroxine-induced hyperthyroidism - an experimental study.
    Bhatt PA; Makwana D
    Fundam Clin Pharmacol; 2008 Feb; 22(1):53-9. PubMed ID: 18251722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-selective and selective beta-1-adrenoceptor blocking agents in the treatment of hyperthyroidism.
    Nilsson OR; Karlberg BE; Kågedal B; Tegler L; Almqvist S
    Acta Med Scand; 1979; 206(1-2):21-5. PubMed ID: 484256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Acute effects of beta receptor blockaders in hyperthyroidism].
    Váradi A; Földes J; Gyertyánffy G; Borvendég J; Brüll J
    Orv Hetil; 1981 May; 122(18):1069-72. PubMed ID: 6115351
    [No Abstract]   [Full Text] [Related]  

  • 10. Thyroxine and triiodothyronine levels in hyperthyroid patients during treatment with propranolol.
    Harrower AD; Fyffe JA; Horn DB; Strong JA
    Clin Endocrinol (Oxf); 1977 Jul; 7(1):41-4. PubMed ID: 880733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of atenolol on serum thyroid hormones in hyperthyroid patients.
    How J; Khir AS; Bewsher PD
    Clin Endocrinol (Oxf); 1980 Sep; 13(3):299-302. PubMed ID: 7214722
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The effect of the beta-blockers nadolol and metipranolol in patients with thyrotoxicosis].
    Vavrejnová V; Felt V; Nedvídková J
    Cas Lek Cesk; 1985 Oct; 124(43):1320-3. PubMed ID: 2867827
    [No Abstract]   [Full Text] [Related]  

  • 13. Propranolol and thyroid resection for thyperthyroidism.
    Anderberg B; Kågedal B; Nilsson OR; Smeds S; Tegler L; Gillquist J
    Acta Chir Scand; 1979; 145(5):297-303. PubMed ID: 43060
    [No Abstract]   [Full Text] [Related]  

  • 14. [On the effect of beta-adrenergic receptor blocking agents in thyroitoxic cardiopathies in the aged. (Statistical study)].
    Pasoli CA; Forte PL; Luzi-Crivellini A; Pasoli A; Girelli Bruni E; Bellini P
    Fracastoro; 1970; 63(1):18-32. PubMed ID: 4394523
    [No Abstract]   [Full Text] [Related]  

  • 15. [The beta-blocking drugs in hyperthyroidism. I. Effects on the cardiovascular syndrome].
    Ghidini O; Bellotti G; De Gregori ME; Salazzari G; Giardina F
    Minerva Med; 1971 Mar; 62(26):1363-73. PubMed ID: 4396565
    [No Abstract]   [Full Text] [Related]  

  • 16. Block of adrenergic beta-receptors by propranolol in the treatment of thyrotoxicosis.
    Felt V
    Rev Czech Med; 1970; 16(3):140-4. PubMed ID: 4393594
    [No Abstract]   [Full Text] [Related]  

  • 17. Preliminary report on the use of propranolol in thyrotoxicosis: I. Effect on serum thyroxine, triiodothyronine and reverse triiodothyronine concentrations.
    Tevaarwerk GJ; Malik MH; Boyd D
    Can Med Assoc J; 1978 Aug; 119(4):350-1, 360. PubMed ID: 688126
    [No Abstract]   [Full Text] [Related]  

  • 18. The influence of beta-adrenoceptor blocking agents on plasma thyroxine and triiodothyronine.
    Wiersinga WM; Touber JL
    J Clin Endocrinol Metab; 1977 Aug; 45(2):293-8. PubMed ID: 885993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propranolol induced reduction in serum T3-A biochemical index of beta-adrenergic blockade in hyperthyroidism.
    Feely J
    Horm Metab Res; 1980; 12(6):279-80. PubMed ID: 6105995
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical-pharmacological evaluation of a new beta blocker, GYKI-41099 (tobanum).
    Török E; Istvánffy M; Halmágyi M; Wagner M; Csukás M
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):200-7. PubMed ID: 6104634
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.